{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:46:46Z","timestamp":1792511206586,"version":"4.5.0"},"reference-count":165,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Dutch Research Council","doi-asserted-by":"publisher","award":["OCENW.XS23.4.123"],"award-info":[{"award-number":["OCENW.XS23.4.123"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"Netherlands Organisation for Health Research and Development","doi-asserted-by":"publisher","award":["10250022110004"],"award-info":[{"award-number":["10250022110004"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018694","name":"European Commission Marie Sklodowska-Curie Actions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["NNF21CC0073729"],"award-info":[{"award-number":["NNF21CC0073729"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.xcrm.2026.103079","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:13:31Z","timestamp":1790349211000},"page":"103079","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Human iPSC models of myocardial infarction: From injury to repair and therapeutic discovery"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6280-8385","authenticated-orcid":false,"given":"Benjamin B.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine L.","family":"Mummery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7917-9423","authenticated-orcid":false,"given":"Richard P.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.103079_bib1","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/eurjpc\/zwae281","article-title":"Global burden of cardiovascular diseases: projections from 2025 to 2050","volume":"32","author":"Chong","year":"2025","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.xcrm.2026.103079_bib2","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.jacc.2022.11.001","article-title":"Global Burden of Cardiovascular Diseases and Risks Collaboration, 1990-2021","volume":"80","author":"Lindstrom","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.xcrm.2026.103079_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2022.100342","article-title":"Ten things to know about ten cardiovascular disease risk factors - 2022","volume":"10","author":"Bays","year":"2022","journal-title":"Am. J. Prev. Cardiol."},{"key":"10.1016\/j.xcrm.2026.103079_bib4","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1161\/CIR.0000000000001258","article-title":"Forecasting the Economic Burden of Cardiovascular Disease and Stroke in the United States Through 2050: A Presidential Advisory From the American Heart Association","volume":"150","author":"Kazi","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.xcrm.2026.103079_bib5","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1093\/eurheartj\/ehad583","article-title":"Economic burden of cardiovascular diseases in the European Union: a population-based cost study","volume":"44","author":"Luengo-Fernandez","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.xcrm.2026.103079_bib6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pop.2017.10.004","article-title":"Cardiovascular Disease in Women","volume":"45","author":"Leonard","year":"2018","journal-title":"Prim. Care"},{"key":"10.1016\/j.xcrm.2026.103079_bib7","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/ehjqcco\/qcac014","article-title":"European Society of Cardiology: cardiovascular disease statistics 2021: Executive Summary","volume":"8","author":"Timmis","year":"2022","journal-title":"Eur. Heart J. Qual. Care Clin. Outcomes"},{"key":"10.1016\/j.xcrm.2026.103079_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00395-022-00909-8","article-title":"Coronary blood flow in heart failure: cause, consequence and bystander","volume":"117","author":"Heusch","year":"2022","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.xcrm.2026.103079_bib9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.medj.2023.12.007","article-title":"Myocardial ischemia\/reperfusion: Translational pathophysiology of ischemic heart disease","volume":"5","author":"Heusch","year":"2024","journal-title":"Med"},{"key":"10.1016\/j.xcrm.2026.103079_bib10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41569-021-00607-3","article-title":"Epidemiology of cardiovascular disease in Europe","volume":"19","author":"Townsend","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.xcrm.2026.103079_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2023.101604","article-title":"Gender and CVD- Does It Really Matters?","volume":"48","author":"Suman","year":"2023","journal-title":"Curr. Probl. Cardiol."},{"key":"10.1016\/j.xcrm.2026.103079_bib12","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1002\/j.2040-4603.2015.tb00664.x","article-title":"Pathophysiology of Myocardial Infarction","volume":"5","author":"Frangogiannis","year":"2015","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.xcrm.2026.103079_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2021.12.013","article-title":"Ischemia and no obstructive coronary arteries in patients with stable ischemic heart disease","volume":"348","author":"Mehta","year":"2022","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.xcrm.2026.103079_bib14","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.jacc.2006.02.002","article-title":"Regeneration gaps: observations on stem cells and cardiac repair","volume":"47","author":"Murry","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.xcrm.2026.103079_bib15","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.jacc.2021.08.001","article-title":"Primary PCI, Late Presenting STEMI, and the Limits of Time","volume":"78","author":"Kastrati","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.xcrm.2026.103079_bib16","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41392-022-00925-z","article-title":"Signaling pathways and targeted therapy for myocardial infarction","volume":"7","author":"Zhang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.xcrm.2026.103079_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2022.101398","article-title":"Novel Therapeutic Strategies to Reduce Reperfusion Injury After Acute Myocardial Infarction","volume":"47","author":"Sch\u00e4fer","year":"2022","journal-title":"Curr. Probl. Cardiol."},{"key":"10.1016\/j.xcrm.2026.103079_bib18","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1161\/ATVBAHA.120.314346","article-title":"Exploring the Role of Endothelial Cell Resilience in Cardiovascular Health and Disease","volume":"41","author":"Gao","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.xcrm.2026.103079_bib19","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41569-023-00913-y","article-title":"The role of cardiac pericytes in health and disease: therapeutic targets for myocardial infarction","volume":"21","author":"Avolio","year":"2024","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.xcrm.2026.103079_bib20","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1161\/CIRCRESAHA.124.323892","article-title":"Cardiac Fibroblastic Niches in Homeostasis and Inflammation","volume":"134","author":"Cadosch","year":"2024","journal-title":"Circ. Res."},{"key":"10.1016\/j.xcrm.2026.103079_bib21","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00109-017-1575-8","article-title":"Mechanisms of foam cell formation in atherosclerosis","volume":"95","author":"Chistiakov","year":"2017","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.xcrm.2026.103079_bib22","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","article-title":"The changing landscape of atherosclerosis","volume":"592","author":"Libby","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.103079_bib23","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/CRD.0000000000000440","article-title":"Pathobiology of Myocardial Ischemia and Reperfusion Injury: Models, Modes, Molecular Mechanisms, Modulation, and Clinical Applications","volume":"31","author":"Buja","year":"2023","journal-title":"Cardiol. Rev."},{"key":"10.1016\/j.xcrm.2026.103079_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165768","article-title":"Mitochondrial ROS in myocardial ischemia reperfusion and remodeling","volume":"1866","author":"Bugger","year":"2020","journal-title":"Biochim. Biophys. Acta. Mol. Basis Dis."},{"key":"10.1016\/j.xcrm.2026.103079_bib25","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1111\/jcmm.15127","article-title":"Mitochondrial and mitochondrial-independent pathways of myocardial cell death during ischaemia and reperfusion injury","volume":"24","author":"Davidson","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.xcrm.2026.103079_bib26","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1161\/ATVBAHA.111.224915","article-title":"Mechanisms of cell death in heart disease","volume":"32","author":"Konstantinidis","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.xcrm.2026.103079_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/ajpheart.00093.2022","article-title":"Myocardial injury, troponin release, and cardiomyocyte death in brief ischemia, failure, and ventricular remodeling","volume":"323","author":"Canty","year":"2022","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.xcrm.2026.103079_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.452","article-title":"Co-expression of POU4F2\/Brn-3b with p53 may be important for controlling expression of pro-apoptotic genes in cardiomyocytes following ischaemic\/hypoxic insults","volume":"5","author":"Budhram-Mahadeo","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.xcrm.2026.103079_bib29","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41569-022-00823-5","article-title":"Macrophages in cardiac remodelling after myocardial infarction","volume":"20","author":"Yap","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.xcrm.2026.103079_bib30","article-title":"The role of major immune cells in myocardial infarction","volume":"13","author":"Feng","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.103079_bib31","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/CIRCULATIONAHA.110.982777","article-title":"Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia\/reperfusion injury","volume":"123","author":"Kawaguchi","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.xcrm.2026.103079_bib32","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrcardio.2014.28","article-title":"The inflammatory response in myocardial injury, repair, and remodelling","volume":"11","author":"Frangogiannis","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.xcrm.2026.103079_bib33","doi-asserted-by":"crossref","first-page":"H23","DOI":"10.1530\/VB-19-0007","article-title":"Pericytes in the infarcted heart","volume":"1","author":"Alex","year":"2019","journal-title":"Vasc. Biol."},{"key":"10.1016\/j.xcrm.2026.103079_bib34","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00441-016-2431-9","article-title":"Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration","volume":"365","author":"Talman","year":"2016","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.xcrm.2026.103079_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-20736-w","article-title":"Transcriptomic dynamics of cardiac remodeling after myocardial infarction","volume":"15","author":"Sanjaya","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2026.103079_bib36","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.mvr.2010.03.014","article-title":"Vascular endothelial growth factor (VEGF)-A: role on cardiac angiogenesis following myocardial infarction","volume":"80","author":"Zhao","year":"2010","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.xcrm.2026.103079_bib37","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1161\/01.CIR.101.25.2981","article-title":"Left ventricular remodeling after myocardial infarction: pathophysiology and therapy","volume":"101","author":"Sutton","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.xcrm.2026.103079_bib38","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3389\/fphys.2018.00356","article-title":"Modeling the Electrophysiological Properties of the Infarct Border Zone","volume":"9","author":"Mendonca Costa","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.xcrm.2026.103079_bib39","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10741-023-10345-y","article-title":"The sympathetic nervous system in heart failure revisited","volume":"29","author":"Triposkiadis","year":"2024","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.xcrm.2026.103079_bib40","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/cvr\/cvaa324","article-title":"Cardiac fibrosis","volume":"117","author":"Frangogiannis","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.xcrm.2026.103079_bib41","doi-asserted-by":"crossref","first-page":"H812","DOI":"10.1152\/ajpheart.00335.2017","article-title":"Guidelines for experimental models of myocardial ischemia and infarction","volume":"314","author":"Lindsey","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.xcrm.2026.103079_bib42","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/bph.15595","article-title":"Preclinical models of myocardial infarction: from mechanism to translation","volume":"179","author":"Martin","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.xcrm.2026.103079_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.673683","article-title":"Current Status and Limitations of Myocardial Infarction Large Animal Models in Cardiovascular Translational Research","volume":"9","author":"Shin","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.xcrm.2026.103079_bib44","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/eurheartj\/ehz933","article-title":"Animals in cardiovascular research","volume":"41","author":"Cesarovic","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.xcrm.2026.103079_bib45","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.046565","article-title":"Mouse models of myocardial infarction: comparing permanent ligation and ischaemia-reperfusion","volume":"13","author":"De Villiers","year":"2020","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.xcrm.2026.103079_bib46","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3389\/fphys.2012.00345","article-title":"Cardiac electrophysiology in mice: a matter of size","volume":"3","author":"Kaese","year":"2012","journal-title":"Front. Physiol."},{"key":"10.1016\/j.xcrm.2026.103079_bib47","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0008-6363(98)00073-X","article-title":"Cardiovascular phenotyping in mice","volume":"39","author":"Doevendans","year":"1998","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.xcrm.2026.103079_bib48","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/pr.2014.128","article-title":"A detailed comparison of mouse and human cardiac development","volume":"76","author":"Krishnan","year":"2014","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.xcrm.2026.103079_bib49","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1161\/CIRCRESAHA.116.309126","article-title":"The Need for Speed: Mice, Men, and Myocardial Kinetic Reserve","volume":"119","author":"Janssen","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.xcrm.2026.103079_bib50","doi-asserted-by":"crossref","first-page":"45","DOI":"10.51847\/YJQDk2wtgX","article-title":"Major Causes Associated with Clinical Trials Failure and Selective Strategies to Reduce these Consequences: A Review","volume":"12","author":"Arora","year":"2021","journal-title":"Arch. Pharm. Pract."},{"key":"10.1016\/j.xcrm.2026.103079_bib51","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1161\/CIRCRESAHA.110.227512","article-title":"Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview","volume":"111","author":"Mummery","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.xcrm.2026.103079_bib52","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.103079_bib53","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells","volume":"318","author":"Junying","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.103079_bib54","first-page":"21.3.1","article-title":"Chemically Defined Culture and Cardiomyocyte Differentiation of Human Pluripotent Stem Cells","volume":"87","author":"Burridge","year":"2015","journal-title":"Curr. Protoc. Hum. Genet."},{"key":"10.1016\/j.xcrm.2026.103079_bib55","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-39525-4","article-title":"Comparing the signaling and transcriptome profiling landscapes of human iPSC-derived and primary rat neonatal cardiomyocytes","volume":"13","author":"Bourque","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2026.103079_bib56","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s42826-021-00102-3","article-title":"A comparative review on heart ion channels, action potentials and electrocardiogram in rodents and human: extrapolation of experimental insights to clinic","volume":"37","author":"Joukar","year":"2021","journal-title":"Lab. Anim. Res."},{"key":"10.1016\/j.xcrm.2026.103079_bib57","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.molmed.2011.05.001","article-title":"Pluripotent stem cell models of cardiac disease and their implication for drug discovery and development","volume":"17","author":"Davis","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.xcrm.2026.103079_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252212034","article-title":"The Role of Human-Induced Pluripotent Stem Cells in Studying Cardiac Channelopathies","volume":"25","author":"Begovic","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.xcrm.2026.103079_bib59","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.jacc.2016.07.779","article-title":"Patient-Specific and Genome-Edited Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Brugada Syndrome","volume":"68","author":"Liang","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.xcrm.2026.103079_bib60","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature11799","article-title":"Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs","volume":"494","author":"Kim","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.103079_bib61","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1038\/ncomms7955","article-title":"Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy","volume":"6","author":"Karakikes","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.103079_bib62","doi-asserted-by":"crossref","DOI":"10.1093\/ehjopen\/oeaf161","article-title":"Setting the stage for cardiomyopathy gene editing trials: a systematic review of isogenic pair use in human induced pluripotent stem cell-derived cardiomyocyte research","volume":"6","author":"Van Der Wilt","year":"2026","journal-title":"Eur. Heart J. Open"},{"key":"10.1016\/j.xcrm.2026.103079_bib63","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.stemcr.2018.10.006","article-title":"Isogenic Pairs of hiPSC-CMs with Hypertrophic Cardiomyopathy\/LVNC-Associated ACTC1 E99K Mutation Unveil Differential Functional Deficits","volume":"11","author":"Smith","year":"2018","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.xcrm.2026.103079_bib64","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1093\/eurheartj\/ehy249","article-title":"CRISPR\/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy","volume":"39","author":"Mosqueira","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.xcrm.2026.103079_bib65","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1016\/j.cell.2021.04.034","article-title":"Cardioids reveal self-organizing principles of human cardiogenesis","volume":"184","author":"Hofbauer","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.103079_bib66","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1038\/s41587-023-01718-7","article-title":"Epicardioid single-cell genomics uncovers principles of human epicardium biology in heart development and disease","volume":"41","author":"Meier","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2026.103079_bib67","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20200833","article-title":"Maturation strategies and limitations of induced pluripotent stem cell-derived cardiomyocytes","volume":"41","author":"Wu","year":"2021","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.xcrm.2026.103079_bib68","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.3390\/ijms21093404","article-title":"Modeling Cardiovascular Diseases with hiPSC-Derived Cardiomyocytes in 2D and 3D Cultures","volume":"21","author":"Sacchetto","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.xcrm.2026.103079_bib69","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1038\/s41467-025-58044-6","article-title":"Comprehensive promotion of iPSC-CM maturation by integrating metabolic medium with nanopatterning and electrostimulation","volume":"16","author":"Li","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.103079_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113970","article-title":"Human induced pluripotent stem cell (hiPSC)-derived cardiomyocyte modelling of cardiovascular diseases for natural compound discovery","volume":"157","author":"Zhu","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.xcrm.2026.103079_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2024.1475152","article-title":"Human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) for modeling cardiac arrhythmias: strengths, challenges and potential solutions","volume":"15","author":"Joshi","year":"2024","journal-title":"Front. Physiol."},{"key":"10.1016\/j.xcrm.2026.103079_bib72","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1038\/s41598-021-83740-w","article-title":"Human induced pluripotent stem cell-based platform for modeling cardiac ischemia","volume":"11","author":"H\u00e4kli","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2026.103079_bib73","doi-asserted-by":"crossref","DOI":"10.1063\/1.5000746","article-title":"Modelling ischemia-reperfusion injury (IRI) in vitro using metabolically matured induced pluripotent stem cell-derived cardiomyocytes","volume":"2","author":"Hidalgo","year":"2018","journal-title":"APL Bioeng."},{"key":"10.1016\/j.xcrm.2026.103079_bib74","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.134368","article-title":"In vitro model of ischemic heart failure using human induced pluripotent stem cell-derived cardiomyocytes","volume":"6","author":"Davis","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.xcrm.2026.103079_bib75","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fmolb.2020.00033","article-title":"Is It Time to Start Transitioning From 2D to 3D Cell Culture?","volume":"7","author":"Jensen","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.xcrm.2026.103079_bib76","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.stemcr.2016.04.011","article-title":"Human Engineered Heart Tissue: Analysis of Contractile Force","volume":"7","author":"Mannhardt","year":"2016","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.xcrm.2026.103079_bib77","doi-asserted-by":"crossref","first-page":"7005","DOI":"10.1038\/s41598-017-06385-8","article-title":"Cardiac spheroids as promising in vitro models to study the human heart microenvironment","volume":"7","author":"Polonchuk","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2026.103079_bib78","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.stem.2020.05.004","article-title":"Human-iPSC-Derived Cardiac Stromal Cells Enhance Maturation in 3D Cardiac Microtissues and Reveal Non-cardiomyocyte Contributions to Heart Disease","volume":"26","author":"Giacomelli","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2026.103079_bib79","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12967-024-05986-y","article-title":"Heart-on-a-chip: a revolutionary organ-on-chip platform for cardiovascular disease modeling","volume":"23","author":"Liu","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.xcrm.2026.103079_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1494911","article-title":"Multicellular 3D models to study myocardial ischemia-reperfusion injury","volume":"12","author":"Peletier","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.xcrm.2026.103079_bib81","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1089\/ten.tea.2018.0212","article-title":"Human Tissue-Engineered Model of Myocardial Ischemia-Reperfusion Injury","volume":"25","author":"Chen","year":"2019","journal-title":"Tissue Eng. Part A"},{"key":"10.1016\/j.xcrm.2026.103079_bib82","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.trsl.2019.09.001","article-title":"Bioreactor-based 3D human myocardial ischemia\/reperfusion in vitro model: a novel tool to unveil key paracrine factors upon acute myocardial infarction","volume":"215","author":"Sebasti\u00e3o","year":"2020","journal-title":"Transl. Res."},{"key":"10.1016\/j.xcrm.2026.103079_bib83","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.actbio.2019.05.064","article-title":"In vitro aged, hiPSC-origin engineered heart tissue models with age-dependent functional deterioration to study myocardial infarction","volume":"94","author":"Acun","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.xcrm.2026.103079_bib84","doi-asserted-by":"crossref","first-page":"7996","DOI":"10.1038\/s41467-024-52221-9","article-title":"Engineered model of heart tissue repair for exploring fibrotic processes and therapeutic interventions","volume":"15","author":"Yang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.103079_bib85","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1021\/acsbiomaterials.3c01302","article-title":"Generation of Self-Induced Myocardial Ischemia in Large-Sized Cardiac Spheroids without Alteration of Environmental Conditions Recreates Fibrotic Remodeling and Tissue Stiffening Revealed by Constriction Assays","volume":"10","author":"Paz-Artigas","year":"2024","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.xcrm.2026.103079_bib86","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/ac47d8","article-title":"Biofabrication of advanced in vitro3D models to study ischaemic and doxorubicin-induced myocardial damage","volume":"14","author":"Sharma","year":"2022","journal-title":"Biofabrication"},{"key":"10.1016\/j.xcrm.2026.103079_bib87","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s41551-020-0539-4","article-title":"Human cardiac organoids for the modelling of myocardial infarction and drug cardiotoxicity","volume":"4","author":"Richards","year":"2020","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.xcrm.2026.103079_bib88","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.tibtech.2025.11.016","article-title":"Industrialization of 3D hiPSC-cardiac microtissues for high-throughput cardiac safety and drug discovery screening","volume":"44","author":"De Korte","year":"2026","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.xcrm.2026.103079_bib89","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-22225-w","article-title":"Generation and maturation of human iPSC-derived 3D organotypic cardiac microtissues in long-term culture","volume":"12","author":"Ergir","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2026.103079_bib90","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/s41419-024-06703-9","article-title":"Modeling acute myocardial infarction and cardiac fibrosis using human induced pluripotent stem cell-derived multi-cellular heart organoids","volume":"15","author":"Song","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.xcrm.2026.103079_bib91","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax8005","article-title":"Endothelial extracellular vesicles contain protective proteins and rescue ischemia-reperfusion injury in a human heart-on-chip","volume":"12","author":"Yadid","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2026.103079_bib92","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nmeth.2524","article-title":"Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes","volume":"10","author":"Nunes","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2026.103079_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119741","article-title":"Human cardiac fibrosis-on-a-chip model recapitulates disease hallmarks and can serve as a platform for drug testing","volume":"233","author":"Mastikhina","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.xcrm.2026.103079_bib94","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1021\/acscentsci.9b00052","article-title":"Biowire Model of Interstitial and Focal Cardiac Fibrosis","volume":"5","author":"Wang","year":"2019","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.xcrm.2026.103079_bib95","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41573-020-0079-3","article-title":"Organs-on-chips: into the next decade","volume":"20","author":"Low","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2026.103079_bib96","article-title":"Human Heart Anoxia and Reperfusion Tissue (HEART) Model for the Rapid Study of Exosome Bound miRNA Expression As Biomarkers for Myocardial Infarction","volume":"18","author":"Ellis","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.xcrm.2026.103079_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121336","article-title":"Cardiac ischemia on-a-chip to investigate cellular and molecular response of myocardial tissue under hypoxia","volume":"281","author":"Veldhuizen","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.xcrm.2026.103079_bib98","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.1039\/D5LC00469A","article-title":"Immune-integrated cardiac fibrosis-on-a-chip: a 3D microfluidic device for region-specific immune-cardiac crosstalk in the fibrotic heart","volume":"25","author":"Ji","year":"2025","journal-title":"Lab Chip"},{"key":"10.1016\/j.xcrm.2026.103079_bib99","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth Universal Definition of Myocardial Infarction (2018)","volume":"72","author":"Thygesen","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.xcrm.2026.103079_bib100","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/s41586-022-05060-x","article-title":"Spatial multi-omic map of human myocardial infarction","volume":"608","author":"Kuppe","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.103079_bib101","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ymeth.2007.12.001","article-title":"Apoptosis and necrosis: detection, discrimination and phagocytosis","volume":"44","author":"Krysko","year":"2008","journal-title":"Methods"},{"key":"10.1016\/j.xcrm.2026.103079_bib102","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1186\/s12967-025-07088-9","article-title":"Emerging therapy strategies for energy metabolism in acute myocardial infarction","volume":"23","author":"Ma","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.xcrm.2026.103079_bib103","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/cyto.a.20033","article-title":"Efficacy of MitoTracker Green and CMXrosamine to measure changes in mitochondrial membrane potentials in living cells and tissues","volume":"61","author":"Pendergrass","year":"2004","journal-title":"Cytometry. A."},{"key":"10.1016\/j.xcrm.2026.103079_bib104","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1253\/circj.CJ-66-0242","article-title":"JCS\/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure","volume":"89","author":"Kitai","year":"2025","journal-title":"Circ. J."},{"key":"10.1016\/j.xcrm.2026.103079_bib105","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3390\/cells11061045","article-title":"Cardiac Ischemia On-a-Chip: Antiarrhythmic Effect of Levosimendan on Ischemic Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes","volume":"11","author":"Gaballah","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.xcrm.2026.103079_bib106","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1161\/CIRCRESAHA.117.312067","article-title":"MUSCLEMOTION: A Versatile Open Software Tool to Quantify Cardiomyocyte and Cardiac Muscle Contraction In Vitro and In Vivo","volume":"122","author":"Sala","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.xcrm.2026.103079_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2022.101560","article-title":"A review of protocols for human iPSC culture, cardiac differentiation, subtype-specification, maturation, and direct reprogramming","volume":"3","author":"Lyra-Leite","year":"2022","journal-title":"STAR Protoc."},{"key":"10.1016\/j.xcrm.2026.103079_bib108","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.stem.2026.04.018","article-title":"Human PSC-derived sinoatrial node-cardiac plexus assembloids model innervation-associated maturation of pacemaker systems","volume":"33","author":"Zhang","year":"2026","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2026.103079_bib109","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.1016\/j.cell.2023.10.030","article-title":"Multi-chamber cardioids unravel human heart development and cardiac defects","volume":"186","author":"Schmidt","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.103079_bib110","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.biomaterials.2019.03.023","article-title":"Dissecting hiPSC-CM pacemaker function in a cardiac organoid model","volume":"206","author":"Schulze","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.xcrm.2026.103079_bib111","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2025.1629988","article-title":"Tissue-resident macrophages co-develop with myocardial tissue in human induced pluripotent stem cell-derived organoids","volume":"13","author":"Rockel","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.xcrm.2026.103079_bib112","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.stem.2025.09.011","article-title":"Human heart-macrophage assembloids mimic immune-cardiac interactions and enable arrhythmia disease modeling","volume":"32","author":"O'hern","year":"2025","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2026.103079_bib113","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1038\/s44161-025-00746-7","article-title":"Development and modeling of cardiac autonomic innervation","volume":"4","author":"Patsy","year":"2025","journal-title":"Nat. Cardiovasc. Res."},{"key":"10.1016\/j.xcrm.2026.103079_bib114","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.stemcr.2023.06.001","article-title":"Vascularized hiPSC-derived 3D cardiac microtissue on chip","volume":"18","author":"Arslan","year":"2023","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.xcrm.2026.103079_bib115","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.stem.2024.05.011","article-title":"Primitive macrophages enable long-term vascularization of human heart-on-a-chip platforms","volume":"31","author":"Landau","year":"2024","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2026.103079_bib116","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/bit.21295","article-title":"Analysis of oxygen transport in a diffusion-limited model of engineered heart tissue","volume":"97","author":"Brown","year":"2007","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.xcrm.2026.103079_bib117","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/eurheartj\/ehae667","article-title":"Characterization of dynamic changes in cardiac microstructure after reperfused ST-elevation myocardial infarction by biphasic diffusion tensor cardiovascular magnetic resonance","volume":"46","author":"Rajakulasingam","year":"2025","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.xcrm.2026.103079_bib118","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1111\/cts.13066","article-title":"3D cell culture models: Drug pharmacokinetics, safety assessment, and regulatory consideration","volume":"14","author":"Wang","year":"2021","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.xcrm.2026.103079_bib119","doi-asserted-by":"crossref","DOI":"10.1172\/JCI175824","article-title":"FDA Modernization Act 2.0: transitioning beyond animal models with human cells, organoids, and AI\/ML-based approaches","volume":"133","author":"Zushin","year":"2023","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.103079_bib120","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1016\/j.tibtech.2025.12.011","article-title":"The FDA's plan to phase out animal testing","volume":"44","author":"Gerke","year":"2026","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.xcrm.2026.103079_bib121","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.855763","article-title":"Human Engineered Heart Tissue Models for Disease Modeling and Drug Discovery","volume":"10","author":"Tani","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.xcrm.2026.103079_bib122","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1146\/annurev-pharmtox-010919-023309","article-title":"Unlocking Personalized Biomedicine and Drug Discovery with Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Fit for Purpose or Forever Elusive?","volume":"60","author":"De Korte","year":"2020","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.xcrm.2026.103079_bib123","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1161\/RES.0000000000000291","article-title":"Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Preclinical Cancer Drug Cardiotoxicity Testing: A Scientific Statement From the American Heart Association","volume":"125","author":"Gintant","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.xcrm.2026.103079_bib124","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.vascn.2016.06.002","article-title":"The Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative - Update on progress","volume":"81","author":"Colatsky","year":"2016","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.xcrm.2026.103079_bib125","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202501664","article-title":"Tapered Pillar Design for High-Precision Force Readout in Miniaturized Engineered Heart Tissues From Human Pluripotent Stem Cells","volume":"14","author":"Dostani\u0107","year":"2025","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.xcrm.2026.103079_bib126","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.stem.2024.01.007","article-title":"Strengthening cardiac therapy pipelines using human pluripotent stem cell-derived cardiomyocytes","volume":"31","author":"Raniga","year":"2024","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2026.103079_bib127","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1093\/eurheartj\/ehae519","article-title":"Clinical trials in-a-dish for cardiovascular medicine","volume":"45","author":"Wu","year":"2024","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.xcrm.2026.103079_bib128","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2025.1671013","article-title":"A hypoxia-on-a-chip platform for modeling ischemic arrhythmogenesis and evaluating the effects of levosimendan and OR-1896 on ischemic human iPSC-derived cardiomyocytes","volume":"13","author":"Gaballah","year":"2025","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.xcrm.2026.103079_bib129","doi-asserted-by":"crossref","first-page":"7143","DOI":"10.1016\/j.cell.2024.09.034","article-title":"Multiscale drug screening for cardiac fibrosis identifies MD2 as a therapeutic target","volume":"187","author":"Zhang","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.103079_bib130","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nm.4087","article-title":"Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity","volume":"22","author":"Burridge","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.103079_bib131","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1161\/CIRCULATIONAHA.118.037357","article-title":"Human-Induced Pluripotent Stem Cell Model of Trastuzumab-Induced Cardiac Dysfunction in Patients With Breast Cancer","volume":"139","author":"Kitani","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.xcrm.2026.103079_bib132","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.stem.2016.07.006","article-title":"Transcriptome Profiling of Patient-Specific Human iPSC-Cardiomyocytes Predicts Individual Drug Safety and Efficacy Responses In Vitro","volume":"19","author":"Matsa","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2026.103079_bib133","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1093\/eurheartj\/ehae619","article-title":"Cardiovascular care with digital twin technology in the era of generative artificial intelligence","volume":"45","author":"Thangaraj","year":"2024","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.xcrm.2026.103079_bib134","doi-asserted-by":"crossref","DOI":"10.1093\/stmcls\/sxaf038","article-title":"Healthy human induced pluripotent stem cell-derived cardiomyocytes exhibit sex dimorphism even without the addition of hormones","volume":"43","author":"Givens","year":"2025","journal-title":"Stem Cell."},{"key":"10.1016\/j.xcrm.2026.103079_bib135","doi-asserted-by":"crossref","DOI":"10.1172\/JCI180074","article-title":"Hearts apart: sex differences in cardiac remodeling in health and disease","volume":"134","author":"Martin","year":"2024","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.103079_bib136","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s44385-025-00048-4","article-title":"Progress and challenges in transplantation of human pluripotent stem cell derived cardiomyocytes for cardiac therapy","volume":"3","author":"Bain","year":"2026","journal-title":"NPJ Biomed. Innov."},{"key":"10.1016\/j.xcrm.2026.103079_bib137","first-page":"S0167","article-title":"Epicardial patches for myocardial repair: circumventing barriers to heal ischemic heart tissue","volume":"0","author":"Winkelbauer","year":"2026","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.xcrm.2026.103079_bib138","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1016\/j.ymthe.2025.07.009","article-title":"Pluripotent stem cell-based approaches for heart repair and the potential of genetic modifications","volume":"33","author":"Dulak","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2026.103079_bib139","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020402","article-title":"All Roads Lead to Rome (the Heart): Cell Retention and Outcomes From Various Delivery Routes of Cell Therapy Products to the Heart","volume":"10","author":"Li","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.xcrm.2026.103079_bib140","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2025.115594","article-title":"Human pluripotent stem cell-based cardiac repair: Lessons learned and challenges ahead","volume":"222","author":"Montague","year":"2025","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.xcrm.2026.103079_bib141","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.stem.2014.11.009","article-title":"Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells","volume":"15","author":"Ye","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2026.103079_bib142","doi-asserted-by":"crossref","first-page":"H327","DOI":"10.1152\/ajpheart.00688.2017","article-title":"Spheroids of cardiomyocytes derived from human-induced pluripotent stem cells improve recovery from myocardial injury in mice","volume":"315","author":"Mattapally","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.xcrm.2026.103079_bib143","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.healun.2018.11.002","article-title":"Development of a transplant injection device for optimal distribution and retention of human induced pluripotent stem cell\u2012derived cardiomyocytes","volume":"38","author":"Tabei","year":"2019","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.xcrm.2026.103079_bib144","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s12265-025-10596-0","article-title":"Human Cardiac Microtissues Display Improved Engraftment and Survival in a Porcine Model of Myocardial Infarction","volume":"18","author":"Demkes","year":"2025","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.xcrm.2026.103079_bib145","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1038\/s41467-024-46928-y","article-title":"Versatile human cardiac tissues engineered with perfusable heart extracellular microenvironment for biomedical applications","volume":"15","author":"Min","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.103079_bib146","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.950829","article-title":"Case report: Transplantation of human induced pluripotent stem cell-derived cardiomyocyte patches for ischemic cardiomyopathy","volume":"9","author":"Miyagawa","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.xcrm.2026.103079_bib147","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-024-08463-0","article-title":"Engineered heart muscle allografts for heart repair in primates and humans","volume":"639","author":"Jebran","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.103079_bib148","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.stem.2025.01.003","article-title":"Pluripotent stem-cell-derived therapies in clinical trial: A 2025 update","volume":"32","author":"Kirkeby","year":"2025","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2026.103079_bib149","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1186\/s13287-025-04664-0","article-title":"Human induced pluripotent stem cell-derived cardiomyocytes improve recovery from myocardial infarction in non-human primates","volume":"16","author":"Guan","year":"2025","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.xcrm.2026.103079_bib150","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa2513525","article-title":"Stem-Cell-Derived Biologic Ventricular Assist Tissue in Heart Failure","volume":"394","author":"Zimmermann","year":"2026","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.103079_bib151","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/j.stem.2025.10.008","article-title":"Injury-induced Clusterin+ cardiomyocytes suppress inflammation and promote regeneration in neonatal and adult hearts by reprogramming macrophages","volume":"32","author":"Fan","year":"2025","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2026.103079_bib152","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.stem.2023.04.010","article-title":"Gene editing to prevent ventricular arrhythmias associated with cardiomyocyte cell therapy","volume":"30","author":"Marchiano","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2026.103079_bib153","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1374881","article-title":"Stem cell-derived cardiomyocytes expressing a dominant negative pacemaker HCN4 channel do not reduce the risk of graft-related arrhythmias","volume":"11","author":"Wulkan","year":"2024","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.xcrm.2026.103079_bib154","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-33144-0","article-title":"Graphene Oxide-Gold Nanosheets Containing Chitosan Scaffold Improves Ventricular Contractility and Function After Implantation into Infarcted Heart","volume":"8","author":"Saravanan","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2026.103079_bib155","article-title":"Fabrication and In Vitro Characterization of Polycaprolactone\/Graphene Oxide\/Collagen Nanofibers for Myocardial Repair","volume":"309","author":"Karapehlivan","year":"2023","journal-title":"Macromol. Mater. Eng."},{"key":"10.1016\/j.xcrm.2026.103079_bib156","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.biomaterials.2016.10.026","article-title":"3D printed complex tissue construct using stem cell-laden decellularized extracellular matrix bioinks for cardiac repair","volume":"112","author":"Jang","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.xcrm.2026.103079_bib157","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201801217","article-title":"Decellularized Extracellular Matrix Materials for Cardiac Repair and Regeneration","volume":"8","author":"Bejleri","year":"2019","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.xcrm.2026.103079_bib158","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.7150\/thno.121105","article-title":"Safety and Engraftment of Aligned Cardiac Patches Loaded with hiPSC-CMs in a Large Animal Model of Myocardial Infarction","volume":"16","author":"Sridharan","year":"2026","journal-title":"Theranostics"},{"key":"10.1016\/j.xcrm.2026.103079_bib159","article-title":"Tissue-engineered cardiac patches enriched with IGF1 modified mRNA alleviate myocardial infarction by enhancing cell survival and angiogenesis","volume":"36","author":"Yan","year":"2026","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.xcrm.2026.103079_bib160","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2020.610364","article-title":"Recent Development in Therapeutic Cardiac Patches","volume":"7","author":"Mei","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.xcrm.2026.103079_bib161","article-title":"Controlled Release of Collagen-Binding SDF-1alpha Improves Cardiac Function after Myocardial Infarction by Recruiting Endogenous Stem Cells","volume":"6","author":"Sun","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2026.103079_bib162","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41587-019-0016-3","article-title":"Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients","volume":"37","author":"Deuse","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2026.103079_bib163","article-title":"Hypoimmunogenic hPSC-derived cardiac organoids for immune evasion and heart repair","author":"Silver","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.xcrm.2026.103079_bib164","article-title":"3Rs at the European Medicines Agency: Past and future activities","volume":"2","author":"Empl","year":"2026","journal-title":"NAMTA J."},{"key":"10.1016\/j.xcrm.2026.103079_bib165","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1089\/ten.tec.2013.0571","article-title":"GMP cryopreservation of large volumes of cells for regenerative medicine: active control of the freezing process","volume":"20","author":"Massie","year":"2014","journal-title":"Tissue Eng. Part C Methods"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126004969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126004969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:07:53Z","timestamp":1792508873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126004969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":165,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2666379126004969"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.103079","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human iPSC models of myocardial infarction: From injury to repair and therapeutic discovery","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.103079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102888","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102992","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102962","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.103053","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103079"}}